Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Pandemic H1N1(2009) Influenza Vaccine in Adults With Lymphoid Malignancies on Active Systemic Treatment or Post Stem Cell Transplantation

NCT01016548 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01016548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01016548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Pandemic H1N1(2009) Influenza Vaccine in Adults With Lymphoid Malignancies on Active Systemic Treatment or Post Stem Cell Transplantation
Lead sponsor
University Health Network, Toronto
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2010
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a virus, h1n1 subtype, lymphoma, multiple myeloma